Vivo Capital's book
22 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Tebra Technologies | — | $1.1B | — | — | |
| 35Pharma | — | $950.0M | — | — | |
| Avistone Pharmaceuticals Biotechnology | — | $628.3M | — | — | |
| Provivi | — | $420.0M | — | — | |
| BlossomHill Therapeutics | — | $413.1M | — | — | |
| Ossium Health | — | $325.0M | — | — | |
| Immunofoco Biotechnology | — | $298.1M | — | — | |
| Pulmocide | — | $291.6M | — | — | |
| Magnolia Medical Technologies | — | $244.0M | — | — | |
| Korsana Biosciences | — | $243.5M | — | — | |
| + 12 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 22 recorded positions
- ·Watchlist + alerts for Vivo Capital's activity
Create free account
No card required